Ligand profile
KFZ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_1513 — dihydroorotate dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
KFZ- PDB
3zwt- UniProt (similar protein)
Q02127- Target protein
- VK055_1513
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 63.3
- −1 ≤ LogP ≤ 5 3.99
- MW ≤ 500 Da 355.3
- LogP ≤ 5 3.99
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 63.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCc1cc(n2c(n1)nc(n2)SCc3cc(ccc3Cl)Cl)OCCc1cc(n2c(n1)nc(n2)SCc3cc(ccc3Cl)Cl)O
InChI=1S/C14H12Cl2N4OS/c1-2-10-6-12(21)20-13(17-10)18-14(19-20)22-7-8-5-9(15)3-4-11(8)16/h3-6,21H,2,7H2,1H3InChI=1S/C14H12Cl2N4OS/c1-2-10-6-12(21)20-13(17-10)18-14(19-20)22-7-8-5-9(15)3-4-11(8)16/h3-6,21H,2,7H2,1H3
HVAYQTZQQDSNCH-UHFFFAOYSA-NHVAYQTZQQDSNCH-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01180
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand KFZ →
- PDB RCSB structure 3zwt →
- UniProt UniProt Q02127 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “KFZ”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1513.
PDB 74
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).